Konrad, M <br/><br/>
HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome.  [electronic resource] 

 -  Pediatric nephrology (Berlin, Germany)  Feb 1997 
 - 16-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0931-041X 
<br/><br/><label>Standard No.: </label>10.1007/s004670050224  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age of Onset<br/>Alkylating Agents--therapeutic use<br/>Anti-Inflammatory Agents--therapeutic use<br/>Child<br/>Child, Preschool<br/>Chlorambucil--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>DNA--analysis<br/>Female<br/>HLA-DR7 Antigen--blood<br/>Humans<br/>Infant<br/>Male<br/>Nephrotic Syndrome--blood<br/>Polymorphism, Restriction Fragment Length<br/>Prednisone--therapeutic use<br/>Retrospective Studies<br/>Steroids--therapeutic use